Stock AnalizAvantor, Inc. AVTR
Biotechnology: Laboratory Analytical Instruments · IPO 2019 · data as of November 13, 2026
Avantor, Inc. (AVTR) is a industrial company listed in the US with a market value of about $10.5B. In the twelve months to September 30, 2026 it had revenue of $6.6B and net income of $337M, a net margin of 5.1%.
Its overall Stock Analiz score is 0.6 out of 5 (weak). The strongest part is financial health (2/5); the weakest is value (0/5).
Key numbers: a P/E of 31.1, a price to free cash flow of 24.0, 5-year revenue growth of 0% a year, a 5-year average ROIC of 5%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 47% below the current price.
Score: 0.6 / 5
Checks passed
- Positive free cash flow
- Liabilities below 60% of assets
- Stock-based pay below 5% of revenue
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
Valuation
Growth and quality
Financials, last 9 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.6B | $6.6B | $6.8B | $7.0B | $7.5B | $7.4B | $6.4B | $6.0B | $5.9B | $1.2B |
| Net income | $337M | -$530M | $712M | $321M | $686M | $573M | $117M | $38M | -$87M | -$113M |
| Free cash flow | $439M | $495M | $692M | $724M | $710M | $842M | $868M | $302M | $163M | -$193M |
| EPS (diluted) | $0.50 | $-0.78 | $1.04 | $0.47 | $1.01 | $0.85 | $0.09 | $-0.84 | $-2.69 | $-2.75 |
| Net margin | 5.1% | -8.1% | 10.5% | 4.6% | 9.1% | 7.8% | 1.8% | 0.6% | -1.5% | -9.0% |
| ROIC | — | -2.0% | 8.9% | 5.0% | 8.1% | 6.5% | 7.2% | 6.7% | 8.2% | — |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 13 analysts is $17.35, 12% above the current price; targets range from $16.00 to $19.00; the consensus rating is “Hold”; expected EPS is $0.82 for the fiscal year ending December 31, 2026.
Frequently asked questions
What is Avantor’s P/E ratio?
About 31.1, based on the last twelve months of diluted earnings per share (forward P/E about 18.1).
Is Avantor stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 47% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Avantor pay a dividend?
Not currently.
Is Avantor a good stock to buy?
We do not give buy or sell advice. Avantor scores 0.6 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.